论文信息 - International DLBCL Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures: a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC/BCL2 protein coexpression contributes to the inferior survival of - 字舞流文

International DLBCL Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures: a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC/BCL2 protein coexpression contributes to the inferior survival of

W. Choi | R. Gascoyne | G. Slack | G. Bhagat | Y. Zu | Z. Xu-Monette | K. Richards | J. Huh | S. Montes-Moreno | A. Ferreri | K. Dybkaer | A. Tzankov | A. Orazi | A. Balasubramanyam | J. Krieken | T. Green | M. Ponzoni | Ken H Young | Roberto N. Miranda | Shimin Hu | Lin Wu | Wei-min Liu | April Chiu | Qin Huang | Weiyun Ai | Fan Zhou | Meifeng Tu | Daina Variakojis | Weina Chen | Ronald S. Go | Miguel A. Piris | Michael B. Møller | Xiao-ming Zhao | Carlo Visco | Yong Li | E. Hsi | L. J. Medeiros